University of Kansas Cancer Center Post San Antonio Review
Playback speed
10 seconds
48 y/o PALB2 Mutation Carrier With T2N0 ER/PR+, HER2- BC: How to Counsel This Patient? What Treatment to Recommend in the Metastatic Setting?
273 views
February 28, 2021
Login to view comments.
Click here to Login
2021